| VALIRX PLC LS-,001 |
| Großbritannien |
| Gesundheit |
| GB00BLH13C52 / A2P1SH |
| EAJF (Frankfurt) |
| FRA:EAJF, ETR:EAJF, EAJF:GR |
| - |
| https://www.valirx.com/ |
|
ValiRx Plc is a biotechnology company specializing in the development of novel treatments for cancer and other diseases. The company primarily focuses on the translation of scientific discoveries into effective clinical therapies, playing a vital rol..
>Volltext.. |
| 2.59 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| VALIRX |
| 05.04.26 |
|